SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-17-002244
Filing Date
2017-04-25
Accepted
2017-04-25 17:01:29
Documents
4
Period of Report
2017-06-16
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT txmd-def14a_042517.htm DEF 14A 744307
2 GRAPHIC txmddef14a001.jpg GRAPHIC 10504
3 GRAPHIC txmddef14a002.jpg GRAPHIC 10516
4 GRAPHIC proxycard001.jpg GRAPHIC 3402
  Complete submission text file 0001387131-17-002244.txt   779713
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 17781746
SIC: 2834 Pharmaceutical Preparations